Despite global efforts that have reduced tuberculosis (TB) deaths, recent US foreign aid cuts threaten to undo this progress, especially in countries that rely on this funding. As a result, latent TB infections remain largely untested due to cost constraints, and regional TB rates are on the rise.
How will the recent cuts to US foreign aid impact global TB efforts, especially in Southeast Asia, and what role can Singapore play in filling this gap?
Hear from Prof Hsu Li Yang as he delves into the importance of continued global cooperation to combat the ongoing TB crisis and avoid losing ground in global health.